- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07518680
A Clinical Study on the Effect of Massaging Tian Tu Acupoint on Coughing After Esophageal Surgery
April 1, 2026 updated by: Shanghai Zhongshan Hospital
This study is a single-center, self-controlled trial.
Patients will successively undergo voluntary coughing without intervention, a washout period, coughing stimulated by pressing the Tiantu acupoint, a washout period, and voluntary coughing without intervention.
Vital signs of the patients before and after each cough will be recorded, as well as the changes in peak cough flow rate and intra-abdominal pressure after each cough.
For peak cough flow rate and intra-abdominal pressure, three sets of data will be collected each time, and the best value will be taken.
This pilot trial is conducted to verify the feasibility of the research design and to provide sample size estimation and data support for the main study.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
This study is a single-center, self-controlled trial.
Patients will successively undergo voluntary coughing without intervention, a washout period, coughing stimulated by pressing the Tiantu acupoint, another washout period, and voluntary coughing without intervention.
Vital signs of the patients before and after each cough will be recorded, as well as the changes in peak cough flow rate and intra-abdominal pressure after each cough.
Three sets of data will be collected for peak cough flow rate and intra-abdominal pressure each time, and the best value will be taken.
The force, angle, and method of pressing are all specified with specific values.
The finger pressure is measured by a pressure gauge at 1.59 to 3.45 N, each press lasts for 4 seconds, with an interval of 5 minutes, and is repeated three times.
This pilot trial is conducted to verify the feasibility of the research design and provide sample size estimation and data support for the main study.
It mainly focuses on patients after esophageal surgery to investigate whether pressing the Tiantu acupoint can effectively improve the coughing ability of patients.
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Minjie Ju, ScD
- Phone Number: 19180861785
- Email: 2943045720@qq.com
Study Locations
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 200032
- Zhongshan Hospital
-
Contact:
- Minjie Ju, ScD
- Phone Number: 19180861785
- Email: 2943045720@qq.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Voluntarily sign the informed consent form and follow the requirements of the protocol;
- Age 18 to 75 years old (inclusive), gender not limited;
- Patients who have undergone esophageal surgery (without intubation);
- Not taking psychotropic drugs, mentally sound, and likely to cooperate in completing the assessment and intervention.
Exclusion Criteria:
- The subjects or their family members request to withdraw from the study;
- Pregnancy or lactation period;
- Severe heart and lung diseases (such as heart failure, acute exacerbation of COPD, asthma, etc.);
- Skin damage or infection in the area of the Tiantu acupoint;
- Within the last month, have received other cough-related interventions (such as acupuncture, physical therapy);
- Other situations that the researcher deems unsuitable for participating in this clinical trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pressing the Tiantu acupoint to stimulate coughing
At the end of the patient's inhalation, trained and qualified personnel with qualifications perform the compression.
The right thumb or middle and index fingers are flexed and use the tips of the fingers to press on the patient's thyroid cartilage point (the thyroid cartilage point is located on the anterior midline of the neck, in the center of the supra-sternal fossa).
Press vertically inward, with the tips of the fingers touching each other closely, aiming to cause itching in the throat.
Stimulate the trachea to trigger a cough.
The force should be at the minimum level that can produce a cough reflex.
The pressure of the fingers is measured using a pressure gauge, which is 1.59 to 3.45 N.
Each compression lasts for 4 seconds, with an interval of 5 minutes.
Repeat this process 3 times (select the best value).
|
At the end of inhalation, press the Tiantu acupoint to stimulate coughing.
The specific operation method has been mentioned earlier.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cough peak expiratory flow rate at each time point
Time Frame: Baseline, during acupoint stimulation, and 30 minutes post-stimulation
|
The maximum expiratory flow rate generated in the airway when coughing forcefully and rapidly.
Measured by a portable peak flow meter sealed at the patient's mouth during coughing.
It is a crucial and objective quantitative indicator for evaluating cough efficiency and the strength of the expiratory muscles.
|
Baseline, during acupoint stimulation, and 30 minutes post-stimulation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in intra-abdominal pressure at each time point
Time Frame: Baseline, during acupoint stimulation, and 30 minutes post-stimulation
|
The change in intra-abdominal pressure is the key driving force for effective coughing and can be used to assess the strength of the cough.
Measured by bladder manometry, the baseline value before coughing and the peak value during coughing are recorded, and the difference is calculated to assess cough strength.
|
Baseline, during acupoint stimulation, and 30 minutes post-stimulation
|
|
Oxygen saturation at each time point
Time Frame: Baseline, during acupoint stimulation, and 30 minutes post-stimulation
|
Oxygen saturation (SpO2) recorded from the bedside patient monitor.
It can indirectly assess the effectiveness of the patient's coughing after Tiantu acupoint stimulation.
|
Baseline, during acupoint stimulation, and 30 minutes post-stimulation
|
|
Blood pressure at each time point
Time Frame: Baseline, during acupoint stimulation, and 30 minutes post-stimulation
|
Blood pressure recorded from the bedside patient monitor.
Used to assess the safety of Tiantu acupoint stimulation by comparing hemodynamic fluctuations between stimulated and unstimulated coughing.
|
Baseline, during acupoint stimulation, and 30 minutes post-stimulation
|
|
Heart rate at each time point
Time Frame: Baseline, during acupoint stimulation, and 30 minutes post-stimulation
|
Heart rate recorded from the bedside patient monitor.
Used to assess the safety of Tiantu acupoint stimulation by comparing heart rate fluctuations between stimulated and unstimulated coughing.
|
Baseline, during acupoint stimulation, and 30 minutes post-stimulation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Minjie Ju, ScD, Shanghai Zhongshan Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 10, 2026
Primary Completion (Estimated)
May 10, 2026
Study Completion (Estimated)
May 31, 2026
Study Registration Dates
First Submitted
January 29, 2026
First Submitted That Met QC Criteria
April 1, 2026
First Posted (Actual)
April 8, 2026
Study Record Updates
Last Update Posted (Actual)
April 8, 2026
Last Update Submitted That Met QC Criteria
April 1, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B2025-455R
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Esophageal Neoplasms
-
Sun Yat-sen UniversityCompletedEsophageal Adenocarcinoma | Esophageal Carcinoma | Esophagectomy | PaO2 | Esophageal Anastomotic LeakeageChina
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedStage IIIA Esophageal Adenocarcinoma | Stage IIIB Esophageal Adenocarcinoma | Stage IIIC Esophageal Adenocarcinoma | Stage IIB Esophageal Adenocarcinoma | Stage IB Esophageal Adenocarcinoma | Stage IIA Esophageal AdenocarcinomaUnited States
-
Institute of Oncology LjubljanaCompletedEsophageal Cancer | Esophageal CarcinomaSlovenia
-
University Hospital, LilleFederation of Research in Surgery (FRENCH); French Eso-Gastric Tumors Working... and other collaboratorsCompleted
-
Peking UniversityNot yet recruiting
-
Universitaire Ziekenhuizen KU LeuvenCompletedEsophageal Carcinoma (Squamous Cell Carcinoma - Adenocarcinoma)Belgium
-
Emory UniversityNovartisCompletedEsophageal Cancer | Neoplasms, EsophagealUnited States
-
University of Michigan Rogel Cancer CenterGenentech, Inc.TerminatedLoco-regional Esophageal Cancer
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityWithdrawnStage IIB Esophageal Cancer AJCC v7 | Stage III Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7
-
CellSeed Inc.Terminated
Clinical Trials on Pressing the Tiantu acupoint to stimulate coughing
-
University of PennsylvaniaRecruitingPostoperative Nausea and Vomiting | Bariatric Sleeve GastrectomyUnited States
-
University of Nove de JulhoCompleted